LINAFEXOR

Pharmaceutical preparations for the treatment of immune, inflammatory and metabolic diseases, namely, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease for medical purposes; organotherapy preparations; enzyme preparations for medical purposes; medicines for the treatment of immune, inflammatory and metabolic diseases, namely, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease, for human purposes; chemical preparations for medical purposes, namely for immune, inflammatory and metabolic diseases, particularly, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; the foregoing featuring farnesoid X receptor agonists